Literature DB >> 1875119

Simultaneous resection of colorectal carcinoma and synchronous liver metastases in a district hospital.

G Jatzko1, V Wette, M Müller, P Lisborg, M Klimpfinger, H Denk.   

Abstract

Of 491 patients operated for carcinomas of the colon or rectum between 1984 and 1989, 106 were tumour stage IV, U.I.C.C.(Dukes' 'D') at time of operation. In 22 of these cases a radical resection of the carcinoma of the colon or rectum and of synchronous liver metastases was performed simultaneously. In 20 patients the metastases were confined to one, in two they were found in both hepatic lobes. In one case a solitary metastasis of the lower lobe of the right lung was resected additionally. Three right-sided hemihepatectomies, one extended right hemihepatectomy, five left-sided hemihepatectomies, three left-sided lateral segmentectomies, seven atypical segmental resections and three wedge resections were performed. The mean operation time for the radical resection of the carcinomas of the colon or rectum as well as of the liver metastases was 3.5 (3-5.2)hours. An average of 3 (0-9) blood units were needed intraoperatively. The major liver resections were performed in complete normothermic vascular ischaemia using the finger fracture method. The time of ischaemia ranged between 8 and 25 min. Only 1 of 22 patients died postoperatively (30 days postoperative hospital mortality rate 4.5%). Five of 17 patients were free of tumour 2 years after operation. Eight of 22 were alive 2 years after operation (non-age corrected 2-year survival rate 36.4%), 2 of them are alive more than 5 years after treatment. Our results demonstrate that simultaneous resection of colon or rectum carcinoma and of synchronous (resectable) liver metastases can be performed successfully, even in a district hospital.

Entities:  

Mesh:

Year:  1991        PMID: 1875119     DOI: 10.1007/bf00300206

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  10 in total

1.  Total right hepatic lobectomy for primary hepatoma.

Authors:  T Y LIN; K M CHEN; T K LIU
Journal:  Surgery       Date:  1960-12       Impact factor: 3.982

2.  Factors influencing survival in patients with untreated hepatic metastases.

Authors:  B M Jaffe; W L Donegan; F Watson; J S Spratt
Journal:  Surg Gynecol Obstet       Date:  1968-07

3.  Major hepatic resections for metastatic colorectal cancer.

Authors:  M A Adson; J A Van Heerden
Journal:  Ann Surg       Date:  1980-05       Impact factor: 12.969

4.  Liver resection for metastatic colorectal cancer.

Authors:  S Iwatsuki; C O Esquivel; R D Gordon; T E Starzl
Journal:  Surgery       Date:  1986-10       Impact factor: 3.982

5.  Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection.

Authors:  J G Fortner; J S Silva; R B Golbey; E B Cox; B J Maclean
Journal:  Ann Surg       Date:  1984-03       Impact factor: 12.969

6.  Survival after liver resection for secondary tumors.

Authors:  J H Foster
Journal:  Am J Surg       Date:  1978-03       Impact factor: 2.565

7.  Resection of hepatic metastases from colorectal cancer.

Authors:  M A Adson; J A van Heerden; M H Adson; J S Wagner; D M Ilstrup
Journal:  Arch Surg       Date:  1984-06

8.  Normothermic hepatic vascular exclusion for extensive hepatectomy.

Authors:  C Huguet; B Nordlinger; J J Galopin; P Bloch; D Gallot
Journal:  Surg Gynecol Obstet       Date:  1978-11

9.  [Liver resection in patients with metastases of colorectal cancers. Results and prognostic factors].

Authors:  P Hohenberger; P Schlag; V Schwarz; C Herfarth
Journal:  Chirurg       Date:  1988-06       Impact factor: 0.955

10.  Intraoperative ultrasound of the liver affects operative decision making.

Authors:  G A Parker; W Lawrence; J S Horsley; J P Neifeld; D Cook; J Walsh; W Brewer; M J Koretz
Journal:  Ann Surg       Date:  1989-05       Impact factor: 12.969

  10 in total
  16 in total

1.  Clinical risk score can be used to select patients for staging laparoscopy and laparoscopic ultrasound for colorectal liver metastases.

Authors:  A J Shah; J Phull; M D Finch-Jones
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

2.  Targeted therapies in colorectal cancer: surgical considerations.

Authors:  Carrie Luu; Amanda K Arrington; Hans F Schoellhammer; Gagandeep Singh; Joseph Kim
Journal:  J Gastrointest Oncol       Date:  2013-09

Review 3.  Resection of colorectal liver metastases revisited.

Authors:  J Scheele; C Rudroff; A Altendorf-Hofmann
Journal:  J Gastrointest Surg       Date:  1997 Sep-Oct       Impact factor: 3.452

4.  SSAT/AHPBA Joint Symposium: Today's approaches to colorectal cancer (CRC) liver metastases.

Authors:  W Scott Helton
Journal:  J Gastrointest Surg       Date:  2011-02-01       Impact factor: 3.452

5.  Surgical management of patients with synchronous colorectal liver metastasis: a multicenter international analysis.

Authors:  Skye C Mayo; Carlo Pulitano; Hugo Marques; Jorge Lamelas; Christopher L Wolfgang; Wassila de Saussure; Michael A Choti; Isabelle Gindrat; Luca Aldrighetti; Eduardo Barrosso; Gilles Mentha; Timothy M Pawlik
Journal:  J Am Coll Surg       Date:  2013-02-21       Impact factor: 6.113

6.  Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastases.

Authors:  Yanxin Luo; Lei Wang; Chuangqi Chen; Dianke Chen; Meijin Huang; Yihua Huang; Junsheng Peng; Ping Lan; Ji Cui; Shirong Cai; Jianping Wang
Journal:  J Gastrointest Surg       Date:  2010-07-30       Impact factor: 3.452

7.  First-line treatment with hepatic arterial infusion plus capecitabine vs capecitabine alone for elderly patients with unresectable colorectal liver metastases.

Authors:  Xiaodong Li; Liangrong Shi; Jun Wu; Mei Ji; Jiemin Zhao; Weiguang Qiang; Wenge Ding; Jingting Jiang; Qicheng Lu; Changping Wu
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

8.  Impact of neoadjuvant chemotherapy with FOLFOX/FOLFIRI on disease-free and overall survival of patients with colorectal metastases.

Authors:  Sarah Y Boostrom; David M Nagorney; John H Donohue; Scott Harmsen; Kristine Thomsen; Florencia Que; Michael Kendrick; Kaye M Reid-Lombardo
Journal:  J Gastrointest Surg       Date:  2009-09-16       Impact factor: 3.452

9.  Importance of response to neoadjuvant chemotherapy in patients undergoing resection of synchronous colorectal liver metastases.

Authors:  Peter J Allen; Nancy Kemeny; William Jarnagin; Ronald DeMatteo; Leslie Blumgart; Yuman Fong
Journal:  J Gastrointest Surg       Date:  2003-01       Impact factor: 3.452

Review 10.  Surgical therapy for colorectal metastases to the liver.

Authors:  Timothy M Pawlik; Michael A Choti
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.